These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16789857)

  • 21. Acceptability and factors associated with willingness to receive short messages for improving antiretroviral therapy adherence in China.
    Xiao Y; Ji G; Tian C; Li H; Biao W; Hu Z
    AIDS Care; 2014; 26(8):952-8. PubMed ID: 24359520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.
    Belzer ME; Kolmodin MacDonell K; Clark LF; Huang J; Olson J; Kahana SY; Naar S; Sarr M; Thornton S;
    AIDS Patient Care STDS; 2015 Jun; 29(6):338-45. PubMed ID: 25928772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized Factorial Trial of Phone-Delivered Support Counseling and Daily Text Message Reminders for HIV Treatment Adherence.
    Kalichman SC; Kalichman MO; Cherry C; Eaton LA; Cruess D; Schinazi RF
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):47-54. PubMed ID: 27105048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence issues in children and adolescents receiving highly active antiretroviral therapy.
    Goode M; McMaugh A; Crisp J; Wales S; Ziegler JB
    AIDS Care; 2003 Jun; 15(3):403-8. PubMed ID: 12745395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Cell Phone Support on Psychosocial Outcomes for Youth Living with HIV Nonadherent to Antiretroviral Therapy.
    Sayegh CS; MacDonell KK; Clark LF; Dowshen NL; Naar S; Olson-Kennedy J; van den Berg JJ; Xu J; Belzer M
    AIDS Behav; 2018 Oct; 22(10):3357-3362. PubMed ID: 29948339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
    HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions of HIV infected patients on the use of cell phone as a tool to support their antiretroviral adherence; a cross-sectional study in a large referral hospital in Kenya.
    Kinyua F; Kiptoo M; Kikuvi G; Mutai J; Meyers AF; Muiruri P; Songok E
    BMC Public Health; 2013 Oct; 13():987. PubMed ID: 24143931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
    Martin S; Elliott-DeSorbo DK; Wolters PL; Toledo-Tamula MA; Roby G; Zeichner S; Wood LV
    Pediatr Infect Dis J; 2007 Jan; 26(1):61-7. PubMed ID: 17195708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study.
    Kunutsor S; Walley J; Katabira E; Muchuro S; Balidawa H; Namagala E; Ikoona E
    AIDS Behav; 2010 Dec; 14(6):1347-52. PubMed ID: 20700644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART.
    Davies G; Koenig LJ; Stratford D; Palmore M; Bush T; Golde M; Malatino E; Todd-Turner M; Ellerbrock TV
    AIDS Care; 2006 Nov; 18(8):895-903. PubMed ID: 17012078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project.
    Lyon ME; Trexler C; Akpan-Townsend C; Pao M; Selden K; Fletcher J; Addlestone IC; D'Angelo LJ
    AIDS Patient Care STDS; 2003 Jun; 17(6):299-308. PubMed ID: 12880493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
    Scherpbier HJ; Bekker V; Pajkrt D; Jurriaans S; Lange JM; Kuijpers TW
    Pediatrics; 2007 Mar; 119(3):e705-15. PubMed ID: 17308244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placebo practice trials: a tool to assess and improve adherence readiness.
    Wagner G; Iguchi M; Schneider S; Scott J; Anderson D
    HIV Clin Trials; 2002; 3(6):475-81. PubMed ID: 12501131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.
    Belzer ME; Naar-King S; Olson J; Sarr M; Thornton S; Kahana SY; Gaur AH; Clark LF;
    AIDS Behav; 2014 Apr; 18(4):686-96. PubMed ID: 24271347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.